Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Infection Control

Therapeutic area intelligence for Infection Control with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
3
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Hibiwash →
Medline →

Recent signals(3)

RegulatoryAugust 13, 2026

Medline's Convenience Kits May Contain Non-Sterile BD ChloraPrep Applicators

The FDA has issued a safety signal indicating that certain BD ChloraPrep Applicators included in Convenience Kits manufactured by Medline may not be sterile. This issue is classified as high severity due to its potential impact on patient safety and compliance with regulatory standards.

RegulatoryJuly 10, 2026

FDA Alerts on Non-Sterile BD ChloraPrep Applicators in Medline Convenience Kits

The FDA has issued an alert regarding potential sterility issues with BD ChloraPrep Applicators in Medline's Convenience Kits.

RegulatoryJune 27, 2026

Mölnlycke Health Care Recalls Hibiwash Due to Microbial Contamination

Mölnlycke Health Care is recalling specific batches of Hibiwash due to microbial contamination detected during routine monitoring.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.